secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENvue Medical, Inc. (FEED)
CIK:        0001326706
Form:       8-K
Filed at:   2024-11-22T23:59:59+00:00
Accession:  0001493152-24-047385
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NanoVibronix receives Nasdaq equity deficiency notice; equity of $1.872M below $2.5M minimum
--------------------------------------------------------------------------------

- On Nov 19, 2024, Nasdaq notified NanoVibronix it failed the $2.5M stockholders' equity rule based on $1.872M as of Sep 30, 2024.
- This adds to an existing bid price deficiency; both will be considered at the upcoming Nasdaq Hearings Panel hearing.
- The Company will present a compliance plan and request an extension, but continued listing is not assured.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224047385/0001493152-24-047385-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326706/000149315224047385/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047385

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer